SELLAS Life Sciences Group, Inc. (SLS) Stock Overview
Explore SELLAS Life Sciences Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.
SELLAS Life Sciences Group, Inc. (SLS)
Key Financials
Key Financials
Market Cap
2.6B
P/E Ratio
-66.58
EPS (TTM)
$-0.21
ROE
-0.36%
SLS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SELLAS Life Sciences Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SLS on the NASDAQ shows an RSI of 58.46, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.26 for the NASDAQ listing.
Key metrics behind SELLAS Life Sciences Group, Inc.'s NASDAQ-traded stock include a P/E ratio of -66.58 and a market capitalization of 2.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SLS on the NASDAQ.